Handa Oncol
1 products tracked · names used in filings: Handa Oncol
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Thu 03 Sep 2026🇺🇸 FDA approval
FDA approves Omcazio (cabozantinib laurylsulfate): new formulation or manufacturer
Handa Oncol; NDA220613; New formulation or manufacturer; capsule · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Omcazio cabozantinib laurylsulfate | Approved | 2026-09-03 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.